No Data
Bionano Genomics Announces Presentations at ASH Annual Meeting
Express News | Bionano Announces Presentations at the American Society of Hematology (Ash) Annual Meeting That Underscore Ogm Utility Across Blood Cancer Research and Cell & Gene Therapy
Hold Rating on BioNano Genomics Amid Revenue Shortfall and Strategic Shift
Bionano Genomics Analyst Ratings
Scotiabank Maintains Bionano Genomics(BNGO.US) With Hold Rating, Maintains Target Price $1
Scotiabank Sticks to Their Hold Rating for BioNano Genomics (BNGO)
No Data
SJ66Pegasus : From the end of October until now, I have bought a lot of stocks. Some are very risky and facing delisting, some skyrocketed as soon as I bought them, and some were rarely favored by anyone. In the end, they all made money, except for the stock BNGO, which is the most normal, most bullish, and least likely to fall, but it keeps dropping, indicating a major issue.